Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Articles
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
FDA Grants Approval to Avapritinib for Patients with GIST
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
Recap of FDA Drug Approvals in 2019
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
FDA Will Require Early Assessment of New Targeted Agents That May Be Used in Pediatric Cancers
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
FDA Approvals, News & Updates
,
Web Exclusives
Read More ›
November 11, 2019 — Oncology News & Updates
Web Exclusives
,
FDA Approvals, News & Updates
Read More ›
November 4, 2019 — Oncology News & Updates
Genomic Testing
,
Financial Toxicity
,
Leukemia
,
Web Exclusives
Read More ›
Applying CAR T-Cell Therapies to Solid Tumors: Overcoming Current Challenges
By
Chase Doyle
Web Exclusives
,
Immunotherapy
Read More ›
FDA on In Vitro Diagnostics, Vaping; Cost of Novel Treatments
Web Exclusives
Read More ›
The Evolving Role of Precision Medicine in Clinical Practice
By
Meg Barbor, MPH
Web Exclusives
,
Precision Medicine
Read More ›
Page 3 of 62
1
2
3
4
5
6